Skip to content

Hyperspectral Imaging for finding tumorous tissue colorectal cancer surgery

Hyperspectral Imaging for in-vivo localization of tumorous tissue in colorectal cancer during surgery - Hyperspectral imaging for In-Vivo tumor localisation in colorectal surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58468
Enrollment
10
Registered
2025-07-28
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon cancer, rectal Cancer, colorectal cancer Colon cancer, rectal Cancer, Colorectal cancer

Interventions

The study is designed as a feasibility study to assess the imaging quality and usability of the hyperspectral imaging (HSI) laparoscope during colorectal surgery. The HSI laparoscope is a novel imagin

Sponsors

Antoni van Leeuwenhoek (AVL)
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria:Patients = 18 years oldTNM-stage =T3Scheduled for an open colon or rectal resectionScheduled for HIPEC procedure for colorectal cancerWritten informed consent

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study:Suspected oversensitivity to light; e.g. patient who has had photodynamic therapyThe use of intravenous fluorescent agents close to the area to be resected

Design outcomes

Primary

MeasureTime frame
The primary objective of this study is to assess the usability of the HSI laparoscope in terms of quality of measurements. This information will be used to improve and optimize the design of the HSI laparoscope for use in future trials.

Secondary

MeasureTime frame
The secondary objective of this study is to assess the usability and reception of the data produced by the HSI laparoscope as reported by surgeons; and the surgeons vision of optimal implementation for clinical adoption of the device.

Countries

Netherlands

Contacts

Public ContactM Witteveen

Antoni van Leeuwenhoek (AVL)

ma.witteveen@nki.nl+3120 512 2680

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Apr 17, 2026